Risk factors for diagnostic delay in Chinese patients with hereditary angioedema

被引:18
作者
Liu, S. [1 ,2 ,3 ,4 ]
Wang, X. [1 ,2 ,4 ,5 ]
Xu, Yingyang [1 ,2 ]
Xu, Qun [6 ,7 ]
Zhi, Yuxiang [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Dept Allergy, Beijing, Peoples R China
[2] Peking Union Med Coll Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Sch Clin Med, Beijing, Peoples R China
[4] Peking Union Med Coll, 1 Shuaifuyuan, Beijing 100730, Peoples R China
[5] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Key Lab Endocrinol, Natl Hlth Commiss,Dept Endocrinol, Beijing, Peoples R China
[6] Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Dept Epidemiol & Biostat,Inst Basic Med Sci, Beijing, Peoples R China
[7] Chinese Acad Med Sci, Peking Union Med Coll, Ctr Environm & Hlth Sci, Beijing, Peoples R China
关键词
D O I
10.2500/aap.2019.40.4234
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Hereditary angioedema (HAE) is still underdiagnosed or diagnosed after a serious delay. This study aimed to evaluate the diagnostic delay (DD) and misdiagnosis of HAE, and to explore the risk factors associated with a longer DD. Methods: An Internet-based survey was sent to 129 patients with type 1 and 2 HAE who presented to the Allergy Department, Peking Union Medical College Hospital between 1983 and 2017; 107 patients (82.9%) responded, among whom, a total of 96 patients provided complete information about medical visits. DD was divided into two subperiods according to the lower quartile, i.e., DD <= 6 years and DD > 6 years. Results: The median DD of all 96 patients with HAE was 11.04 years (interquartile range [IQR], 6.06-18.27 years). A significant difference (p < 0.001) in the median DD was found between different decades of onset, i.e., before 1999 (19.75 years [IQR, 13.58-29.50 years]), between 2000 and 2009 (8.67 years [IQR, 5.67-11.04 years]), and between 2010 and 2017 (3.79 years [IQR, 2.29-5.71 years]). Patients with a previous misdiagnosis experienced a longer median delay to complement 1 inhibitor HAE diagnosis (13.17 years [IQR, 7.40-20.50 years]) compared with patients without a previous misdiagnosis (median 6.96 years [IQR, 2.83-10.65 years]; p <= 0.001). According to the logistic regression analysis, a younger age of onset and earlier decade of onset were significant predictors of a DD of >6 years. The most frequently visited departments and most frequently misdiagnosed diseases were summarized. Conclusion: The median DD of patients with HAE was 11.04 years (IQR, 6.06-18.27 years). A younger age of onset and earlier decade of onset were predictors of a DD of >6 years. Seventy-five percent of the patients reported receiving more than one previous misdiagnosis. The patients with a previous misdiagnosis had longer DDs compared with patients without a misdiagnosis.
引用
收藏
页码:343 / 349
页数:7
相关论文
共 17 条
[1]   Hereditary angioedema from the patient's perspective: A follow-up patient survey [J].
Banerji, Aleena ;
Li, Yu ;
Busse, Paula ;
Riedl, Marc A. ;
Holtzman, Nicole S. ;
Li, Huamin Henry ;
Davis-Lorton, Mark ;
Bernstein, Jonathan A. ;
Frank, Michael ;
Castaldo, Anthony J. ;
Long, Janet ;
Zuraw, Bruce ;
Lumry, William ;
Christiansen, Sandra .
ALLERGY AND ASTHMA PROCEEDINGS, 2018, 39 (03) :212-223
[2]   Canadian hereditary angioedema guideline [J].
Betschel, Stephen ;
Badiou, Jacquie ;
Binkley, Karen ;
Hebert, Jacques ;
Kanani, Amin ;
Keith, Paul ;
Lacuesta, Gina ;
Yang, Bill ;
Aygoeren-Puersuen, Emel ;
Bernstein, Jonathan ;
Bork, Konrad ;
Caballero, Teresa ;
Cicardi, Marco ;
Craig, Timothy ;
Farkas, Henriette ;
Longhurst, Hilary ;
Zuraw, Bruce ;
Boysen, Henrik ;
Borici-Mazi, Rozita ;
Bowen, Tom ;
Dallas, Karen ;
Dean, John ;
Lang-Robertson, Kelly ;
Laramee, Benoit ;
Leith, Eric ;
Mace, Sean ;
McCusker, Christine ;
Moote, Bill ;
Poon, Man-Chiu ;
Ritchie, Bruce ;
Stark, Donald ;
Sussman, Gordon ;
Waserman, Susan .
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2014, 10
[3]   Hereditary angioedema: New findings concerning symptoms, affected organs, and course [J].
Bork, K ;
Meng, G ;
Staubach, P ;
Hardt, J .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (03) :267-274
[4]   A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE) [J].
Bork, Konrad .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2016, 51 (02) :183-192
[5]   Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency [J].
Bork, Konrad ;
Hardt, Jochen ;
Witzke, Guenther .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 130 (03) :692-697
[6]   Hereditary angio-oedema in Denmark: a nationwide survey [J].
Bygum, A. .
BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 (05) :1153-1158
[7]   Pediatric Hereditary Angioedema: Onset, Diagnostic Delay, and Disease Severity [J].
Christiansen, Sandra C. ;
Davis, Donna K. ;
Castaldo, Anthony J. ;
Zuraw, Bruce L. .
CLINICAL PEDIATRICS, 2016, 55 (10) :935-942
[8]   Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group [J].
Cicardi, M. ;
Aberer, W. ;
Banerji, A. ;
Bas, M. ;
Bernstein, J. A. ;
Bork, K. ;
Caballero, T. ;
Farkas, H. ;
Grumach, A. ;
Kaplan, A. P. ;
Riedl, M. A. ;
Triggiani, M. ;
Zanichelli, A. ;
Zuraw, B. .
ALLERGY, 2014, 69 (05) :602-616
[9]   A UK national audit of hereditary and acquired angioedema [J].
Jolles, S. ;
Williams, P. ;
Carne, E. ;
Mian, H. ;
Huissoon, A. ;
Wong, G. ;
Hackett, S. ;
Lortan, J. ;
Platts, V. ;
Longhurst, H. ;
Grigoriadou, S. ;
Dempster, J. ;
Deacock, S. ;
Khan, S. ;
Darroch, J. ;
Simon, C. ;
Thomas, M. ;
Pavaladurai, V. ;
Alachkar, H. ;
Herwadkar, A. ;
Abinun, M. ;
Arkwright, P. ;
Tarzi, M. ;
Helbert, M. ;
Bangs, C. ;
Pastacaldi, C. ;
Phillips, C. ;
Bennett, H. ;
El-Shanawany, T. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 175 (01) :59-67
[10]   Review of Select Practice Parameters, Evidence-Based Treatment Algorithms, and International Guidelines for Hereditary Angioedema [J].
Jose, Jaison ;
Zacharias, Jamie ;
Craig, Timothy .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2016, 51 (02) :193-206